We are live on ! Find out more
JG

Jefferies Group Portfolio holdings

AUM $12B
1-Year Est. Return 6.2%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
-6.2%
3 Year Est. Return
+88.85%
5 Year Est. Return
+123.14%
10 Year Est. Return
AUM
$15.7B
AUM Growth
+$5.49B
Cap. Flow
+$4.38B
Cap. Flow %
27.83%
Top 10 Hldgs %
53.48%
Holding
2,544
New
632
Increased
495
Reduced
550
Closed
667

Sector Composition

Rank Sector Weight
1 Industrials 2.16%
2 Consumer Discretionary 1.35%
3 Consumer Staples 1.09%
4 Healthcare 1.06%
5 Technology 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRN icon
1626
Trinity Industries
TRN
$2.97B
$113K ﹤0.01%
+5,762
New +$105K
CHS
1627
DELISTED
Chicos FAS, Inc.
CHS
$113K ﹤0.01%
5,974
+1,906
+47% +$33.7K
HT
1628
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$112K ﹤0.01%
+5,050
New +$114K
RRC icon
1629
Range Resources
RRC
$9.11B
$110K ﹤0.01%
1,303
-12,351
-90% -$961K
CBK
1630
DELISTED
Christopher & Banks Corporation
CBK
$110K ﹤0.01%
+12,874
New +$86.7K
ITMN
1631
DELISTED
INTERMUNE INC
ITMN
$110K ﹤0.01%
7,463
-42,113
-85% -$582K
IWM icon
1632
iShares Russell 2000 ETF
IWM
$80.9B
$108K ﹤0.01%
937
-1,258,567
-100% -$139M
RAI
1633
DELISTED
Reynolds American Inc
RAI
$107K ﹤0.01%
4,298
-10,194
-70% -$257K
TQNT
1634
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
$107K ﹤0.01%
12,801
-4,309
-25% -$34.4K
IJH icon
1635
iShares Core S&P Mid-Cap ETF
IJH
$123B
$106K ﹤0.01%
3,950
LUMO
1636
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$106K ﹤0.01%
+533
New +$94.8K
CSCO icon
1637
Cisco
CSCO
$450B
$103K ﹤0.01%
4,604
-365,074
-99% -$8.08M
PH icon
1638
PUT
Parker-Hannifin
PH
$125B
$103K ﹤0.01%
+800
New +$93K
ALXN
1639
DELISTED
Alexion Pharmaceuticals
ALXN
$102K ﹤0.01%
771
-2,438
-76% -$293K
WPX
1640
PUT
DELISTED
WPX Energy, Inc.
WPX
$102K ﹤0.01%
+5,000
New +$99.8K
SIRI icon
1641
SiriusXM
SIRI
$10B
$100K ﹤0.01%
2,855
-210
-7% -$7.85K
TPH
1642
PUT
DELISTED
Tri Pointe Homes
TPH
$100K ﹤0.01%
+5,000
New +$85.7K
EMR icon
1643
CALL
Emerson Electric
EMR
$82.9B
$98K ﹤0.01%
1,400
-19,900
-93% -$1.33M
BMRN icon
1644
BioMarin Pharmaceuticals
BMRN
$11.5B
$97K ﹤0.01%
1,385
-17,981
-93% -$1.22M
FM
1645
DELISTED
iShares Frontier and Select EM ETF
FM
$95K ﹤0.01%
+2,802
New +$91.3K
UPS icon
1646
United Parcel Service
UPS
$97.6B
$94K ﹤0.01%
891
-24,034
-96% -$2.37M
KERX
1647
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$94K ﹤0.01%
+7,290
New +$87.1K
YELP icon
1648
Yelp
YELP
$1.38B
$93K ﹤0.01%
1,355
-197,045
-99% -$13M
RAD
1649
PUT
DELISTED
Rite Aid Corporation
RAD
$93K ﹤0.01%
920
-113,555
-99% -$12.1M
VRSN icon
1650
VeriSign
VRSN
$25.3B
$92K ﹤0.01%
1,553
-20,778
-93% -$1.14M

Similar funds

Jefferies Group's Q4 2013 Portfolio in Review

As of Q4 2013, Jefferies Group held 2,544 positions worth $15.7B, up 54% from $10.2B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Jefferies Group deployed $4.38B of net new capital in Q4 2013, opening 632 new positions and adding to 495 existing holdings. Its largest new stake was Invesco QQQ Trust: 477,781 shares worth $42M.

By sector, the portfolio is most concentrated in Industrials at 2.2% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $139M trimmed.

  • Jefferies Group's largest Q4 2013 buy was Invesco QQQ Trust: 477,781 shares worth $42M.
  • Jefferies Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $164M increase.
  • Jefferies Group's biggest Q4 2013 reduction was iShares Russell 2000 ETF, cutting an estimated $139M.
  • Jefferies Group fully exited OPTIMER PHARMACEUTICALS, INC. COM STK in Q4 2013, selling an estimated $20.1M.
  • Jefferies Group's ten largest holdings make up 53% of its $15.7B portfolio in Q4 2013.
  • Jefferies Group opened 632 new positions and closed 667 in Q4 2013.
  • Jefferies Group's portfolio value rose 54% quarter-over-quarter to $15.7B.

Based on Jefferies Group's 13F filing for Q4 2013, filed 18 Feb 2014.